â??A Randomised Control Trial on Markatbija churn in Tamak Shvas with special reference to Bronchial Asthmaâ??

Government ayurved college and hospital0 个研究点目标入组 0 人开始时间: 待定最近更新: 2022年4月4日

研究概览

暂无简介。

•1. Patient of Tamak Shvasa presenting the clinical features highlighted in classical literature will be randomly irrespective of sex , caste , religion and socio economical status.
•2. Patient of Tamak Shvasa ageing in between 16 to 60 years will be considered.
•3. Patient from mild to moderate exacerbation of bronchial asthma.
•4. Positive test of reversibility-
•a) symptomatic patients- An improvement of 60 L / min or > 20 % in PEFR 10 min after inhalation of bronchodilator ( salbutamol ) .
•b) Asymptomatic patient 60 L / min or > 20 % fall in PEFR by provocation with physical exercise ( brisk walking for 5-10 min ) followed by reversal upon in Inhalation of bronchodilator ( salbutamol) when assessed after 10 min .
•6. Heemoglobin >10 gm%.
•7. Patient willing and able to participate for 4 weeks.
•8. Patient showing symptoms, signs and medical history of bronchial asthma will be included.

•Patient with active lung disease, patient with lung disease other than bronchial asthma, patient who had major surgeries within 2 weeks prior to screening visited , patient with evidence of malignancy, patient with severe asthma exacerbation, pregnant or lactating , patient with poorly controlled hypertension ( >160/100 mmhg) , patient with uncontrolled diabetes mellitus ( blood sugar fasting >130 mg /dl and post meal 250 mg /dl )

发起方

Government ayurved college and hospital